Blocking cholesterol efflux mechanism is a potential target for antilymphoma therapy

Hiromu Yano 1, Yukio Fujiwara 1, Hasita Horlad 1, Chang Pan 1, Keitaro Kai 2, Daisuke Niino 3, Kumiko Ohsawa 4, Morihiro Higashi 4, Kisato Nosaka 5, Yutaka Okuno 5, Jun-Ichi Tamaru 4, Akitake Mukasa 2, Masao Matsuoka 5, Yoshihiro Komohara 1 6 1Department of Cell Pathology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. 2Department of Neurosurgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. 3Department of Pathology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. 4Department of Pathology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan. 5Department of Hematology, Rhaumatology, and Infectious Diseases, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. 6Center for Metabolic Regulation of Healthy Aging, Kumamoto University, Kumamoto, Japan.

NIINO, Daisuke